Comprehensive Treatment of Angina in Women With Microvascular Dysfunction

NACompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

October 1, 2018

Study Completion Date

October 1, 2018

Conditions
Angina PectorisCoronary Microvascular Disease
Interventions
DIETARY_SUPPLEMENT

Diet

Weight loss achieved by following an evidence-based low energy diet of 800-1200 kcal/day for 12 weeks (Cambridge Weight Plan). Hereafter follow 12 weeks of 'weight maintenance' with consumption of normal heart healthy diet. Goal: total weight loss of at least 10% without significant loss of muscle mass. Monitored and supervised by a dietician

BEHAVIORAL

Training

Aerobic interval training and resistance exercise in group sessions twice weekly throughout the 24-week intervention. Training intensity individually adapted to the restricted calorie intake. Goal: Improved VO2 peak (at least 10%). Monitored by a physiotherapist.

DRUG

Medication (with statin and ACE-inhibition)

Medical treatment for hypertension and/or hypercholesterolemia if systolic blood pressure \> 130 and/or low density lipoprotein (LDL) \> 2.0.

Trial Locations (2)

2000

Frederiksberg Hospital, Dept. of Cardiology, Building 16, Y3, Nordre Fasanvej 57, Frederiksberg

2400

Bispebjerg Hospital, Dept. of Cardiology Y builing 67, 1.floor, Bispebjerg Bakke 23, Copenhagen

All Listed Sponsors
collaborator

University Hospital Bispebjerg and Frederiksberg

OTHER

collaborator

Cambridge Weight Plan Limited

INDUSTRY

lead

Bispebjerg Hospital

OTHER

NCT02910154 - Comprehensive Treatment of Angina in Women With Microvascular Dysfunction | Biotech Hunter | Biotech Hunter